Eagle Asset Management’s Aimmune Therapeutics, Inc. AIMT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-1,035,885
| Closed | -$21.6M | – | 686 |
|
|
2019
Q2 | $21.6M | Sell |
1,035,885
-291,048
| -22% | -$6.06M | 0.11% | 228 |
|
|
2019
Q1 | $29.7M | Buy |
1,326,933
+10,579
| +0.8% | +$236K | 0.16% | 208 |
|
|
2018
Q4 | $31.5M | Sell |
1,316,354
-19,403
| -1% | -$464K | 0.2% | 192 |
|
|
2018
Q3 | $36.4M | Sell |
1,335,757
-11,297
| -0.8% | -$308K | 0.18% | 197 |
|
|
2018
Q2 | $36.2M | Sell |
1,347,054
-53,428
| -4% | -$1.44M | 0.2% | 188 |
|
|
2018
Q1 | $44.6M | Sell |
1,400,482
-593,191
| -30% | -$18.9M | 0.24% | 149 |
|
|
2017
Q4 | $75.2M | Sell |
1,993,673
-248,618
| -11% | -$9.38M | 0.41% | 78 |
|
|
2017
Q3 | $56.4M | Sell |
2,242,291
-27,869
| -1% | -$701K | 0.32% | 106 |
|
|
2017
Q2 | $46.7M | Buy |
2,270,160
+135,374
| +6% | +$2.78M | 0.28% | 130 |
|
|
2017
Q1 | $46.4M | Sell |
2,134,786
-12,365
| -0.6% | -$269K | 0.29% | 106 |
|
|
2016
Q4 | $43.9M | Buy |
2,147,151
+11,061
| +0.5% | +$226K | 0.29% | 113 |
|
|
2016
Q3 | $32M | Buy |
2,136,090
+147,656
| +7% | +$2.21M | 0.22% | 142 |
|
|
2016
Q2 | $21.5M | Buy |
1,988,434
+227,439
| +13% | +$2.46M | 0.15% | 200 |
|
|
2016
Q1 | $23.9M | Buy |
1,760,995
+904,913
| +106% | +$12.3M | 0.17% | 187 |
|
|
2015
Q4 | $15.8M | Buy |
+856,082
| New | +$15.8M | 0.11% | 260 |
|